Amphiregulin

Amphiregulin

Amphiregulin Overview

Molecule Name
Amphiregulin
Synonyms
AR, AREGB, CRDGF, SDGF
Drug Development Progress
Drugs in Clinical Trials2
Approved Drugs0
Highest Development StagePhase 1 Clinical
Target Synonym
AREGB,Colorectum cell-derived growth factor,AR,Schwannoma-Derived Growth Factor,Amphiregulin B,CRDGF,SDGF,SDGF GN
Background
Amphiregulin (AREG), which acts as one of the ligands for epidermal receptor growth factor receptor (EGFR), plays a crucial role in tissue repair, inflammation, and immunity. It is an autocrine growth factor as well as a mitogen for astrocytes, Schwann cells and fibroblasts. It is related to epidermal growth factor (EGF) and transforming growth factor alpha (TGF-alpha). The protein interacts with the EGF/TGF-alpha receptor to promote the growth of normal epithelial cells, and it inhibits the growth of certain aggressive carcinoma cell lines. It also functions in mammary gland, oocyte and bone tissue development. This gene is associated with a psoriasis-like skin phenotype, and is also associated with other pathological disorders, including various types of cancers and inflammatory conditions. [provided by RefSeq, Apr 2014]

Amphiregulin Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
SRN-001SRN-001Phase 1 ClinicalsiRNAgen Therapeutics Inc
Metabolic Dysfunction-Associated Steatotic Liver Disease; Idiopathic Pulmonary Fibrosis; Chronic Kidney Disease-Mineral and Bone Disorder
Details
PMG-1015PMG-1015Phase 1 ClinicalPulmongene Ltd
Idiopathic Pulmonary Fibrosis
Details